Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age (NCT05957549)
Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Preschool Age
🩺 Plain-English Summary (8th-Grade Level)
Individuals with Fragile X Syndrome show differences in how they understand and learn language from infancy. They frequently have lifelong delays in speech and language as well. In addition, they experience other auditory symptoms, including being very sensitive to certain sounds as well as being more sensitive than others to loud sounds. The underlying brain activity for sound perception and speech learning in Fragile X is not well understood, especially in the infant, toddler, and preschool years. This study uses behavioral assessment of speech and language abilities, neuroimaging, and hearing tests to understand how speech and hearing are different in children with Fragile X Syndrome.
Who can join: Review the eligibility criteria below.
Location: Cincinnati Children'S Hospital — Cincinnati, Ohio
Age range: 24 Months to 4 Years
🧪 Interventions in This Study
- Speech discrimination (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Cincinnati Children'S Hospital — Cincinnati, Ohio
📞 Contact the Study Coordinator
Phone: (513) 517-1383
Email: elizabeth.smith3@cchmc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Fragile X Syndrome
- Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge — Cincinnati, Ohio
- An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome — Irvine, California
- Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS — Phoenix, Arizona
- Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant — Cincinnati, Ohio
- Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome — Sherbrooke, Quebec
- Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM) — Phoenix, Arizona
Explore by condition: All Fragile X Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.